These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 2669218)

  • 1. Randomised controlled trial comparing prednisolone alone with cyclophosphamide and low dose prednisolone in combination in cryptogenic fibrosing alveolitis.
    Johnson MA; Kwan S; Snell NJ; Nunn AJ; Darbyshire JH; Turner-Warwick M
    Thorax; 1989 Apr; 44(4):280-8. PubMed ID: 2669218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclophosphamide and low-dose prednisolone in idiopathic pulmonary fibrosis and fibrosing nonspecific interstitial pneumonia.
    Kondoh Y; Taniguchi H; Yokoi T; Nishiyama O; Ohishi T; Kato T; Suzuki K; Suzuki R
    Eur Respir J; 2005 Mar; 25(3):528-33. PubMed ID: 15738299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast chemotactic response elicited by native bronchoalveolar lavage fluid from patients with fibrosing alveolitis.
    Behr J; Adelmann-Grill BC; Krombach F; Beinert T; Schwaiblmair M; Fruhmann G
    Thorax; 1993 Jul; 48(7):736-42. PubMed ID: 8153923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclophosphamide with low or high dose prednisolone for systemic sclerosis lung disease.
    Pakas I; Ioannidis JP; Malagari K; Skopouli FN; Moutsopoulos HM; Vlachoyiannopoulos PG
    J Rheumatol; 2002 Feb; 29(2):298-304. PubMed ID: 11842824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The predictive value of appearances on thin-section computed tomography in fibrosing alveolitis.
    Wells AU; Hansell DM; Rubens MB; Cullinan P; Black CM; du Bois RM
    Am Rev Respir Dis; 1993 Oct; 148(4 Pt 1):1076-82. PubMed ID: 8214928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of fibrosing alveolitis with polymyositis dermatomyositis.
    Maccioni FJ; Colebatch HJ
    Aust N Z J Med; 1990 Dec; 20(6):806-10. PubMed ID: 2291731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intermittent high-dose cyclophosphamide with and without prednisolone: a study of the relationships between toxicity, response and survival in metastatic lung cancer.
    Thatcher N; Wagstaff J; Wilkinson P; Palmer M; Crowther D
    Cancer; 1982 Sep; 50(6):1051-6. PubMed ID: 7049346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced cryptogenic fibrosing alveolitis: preliminary report on treatment with cyclosporin A.
    Alton EW; Johnson M; Turner-Warwick M
    Respir Med; 1989 Jul; 83(4):277-9. PubMed ID: 2692090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of serial bronchoalveolar lavages in assessing the clinical progress of patients with cryptogenic fibrosing alveolitis.
    Turner-Warwick M; Haslam PL
    Am Rev Respir Dis; 1987 Jan; 135(1):26-34. PubMed ID: 3800151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrosing alveolitis associated with systemic sclerosis has a better prognosis than lone cryptogenic fibrosing alveolitis.
    Wells AU; Cullinan P; Hansell DM; Rubens MB; Black CM; Newman-Taylor AJ; Du Bois RM
    Am J Respir Crit Care Med; 1994 Jun; 149(6):1583-90. PubMed ID: 8004317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclophosphamide pulse therapy in idiopathic pulmonary fibrosis.
    Kolb M; Kirschner J; Riedel W; Wirtz H; Schmidt M
    Eur Respir J; 1998 Dec; 12(6):1409-14. PubMed ID: 9877500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma.
    Hoyles RK; Ellis RW; Wellsbury J; Lees B; Newlands P; Goh NS; Roberts C; Desai S; Herrick AL; McHugh NJ; Foley NM; Pearson SB; Emery P; Veale DJ; Denton CP; Wells AU; Black CM; du Bois RM
    Arthritis Rheum; 2006 Dec; 54(12):3962-70. PubMed ID: 17133610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. British Thoracic Society Study on cryptogenic fibrosing alveolitis: Response to treatment and survival.
    Rudd RM; Prescott RJ; Chalmers JC; Johnston ID;
    Thorax; 2007 Jan; 62(1):62-6. PubMed ID: 16769717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycophenolate mofetil as first-line treatment improves clinically evident early scleroderma lung disease.
    Liossis SN; Bounas A; Andonopoulos AP
    Rheumatology (Oxford); 2006 Aug; 45(8):1005-8. PubMed ID: 16490756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis.
    Ziesche R; Hofbauer E; Wittmann K; Petkov V; Block LH
    N Engl J Med; 1999 Oct; 341(17):1264-9. PubMed ID: 10528036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different therapies and factors influencing response to therapy in idiopathic diffuse fibrosing alveolitis.
    Costabel U; Matthys H
    Respiration; 1981; 42(3):141-9. PubMed ID: 7313338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab for the first-line treatment of stage III-IV follicular lymphoma (review of Technology Appraisal No. 110): a systematic review and economic evaluation.
    Papaioannou D; Rafia R; Rathbone J; Stevenson M; Buckley Woods H; Stevens J
    Health Technol Assess; 2012; 16(37):1-253, iii-iv. PubMed ID: 23021127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The management of cryptogenic fibrosing alveolitis in three regions of the United Kingdom.
    Johnston ID; Gomm SA; Kalra S; Woodcock AA; Evans CC; Hind CR
    Eur Respir J; 1993 Jun; 6(6):891-3. PubMed ID: 8339811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis.
    Nicholson AG; Colby TV; du Bois RM; Hansell DM; Wells AU
    Am J Respir Crit Care Med; 2000 Dec; 162(6):2213-7. PubMed ID: 11112140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose intravenous methylprednisolone pulse therapy as initial treatment in cryptogenic fibrosing alveolitis. A pilot study.
    Gulsvik A; Kjelsberg F; Bergmann A; Frøland SS; Rootwelt K; Vale JR
    Respiration; 1986; 50(4):252-7. PubMed ID: 3823635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.